Koers Zhejiang Jiuzhou Pharmaceutical Co., Ltd
Aandelen
603456
CNE100001W36
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
15,6 CNY | +3,24% | +3,17% | -35,56% |
Omzet 2024 * | 6,29 mld. 869 mln. 812 mln. | Omzet 2025 * | 7,25 mld. 1 mld. 936 mln. | Marktkapitalisatie | 14,03 mld. 1,94 mld. 1,81 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,26 mld. 174 mln. 162 mln. | Nettowinst (verlies) 2025 * | 1,59 mld. 219 mln. 205 mln. | EV/omzet 2024 * | 2,23 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,94 x |
K/w-verhouding 2024 * |
11,2
x | K/w-verhouding 2025 * |
8,84
x | Werknemers | 4.877 |
Dividendrendement 2024 * |
3,11% | Dividendrendement 2025 * |
3,62% | Vrij verhandelbaar | 56,68% |
1 dag | +3,24% | ||
1 week | +3,17% | ||
Lopende maand | -12,51% | ||
1 maand | -16,40% | ||
3 maanden | -24,01% | ||
6 maanden | -37,60% | ||
Lopend jaar | -35,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bin Wang
PSD | President | 53 | 06-09-18 |
Yi Jiang Mei
PSD | President | 49 | 06-09-18 |
Yu Jie Sha
DFI | Director of Finance/CFO | 44 | 18-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Li Rong Hua
CHM | Chairman | 56 | 18-11-14 |
Hui Lu Lin
BRD | Director/Board Member | 51 | 18-11-14 |
Wen Li
BRD | Director/Board Member | 72 | 18-11-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.62% | 2 M€ | -16,59% | - | |
0.33% | 12 M€ | -16,71% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 15,6 | +3,24% | 23 260 780 |
25-04-24 | 15,11 | +2,65% | 26 122 290 |
24-04-24 | 14,72 | -1,47% | 16 445 000 |
23-04-24 | 14,94 | +0,67% | 17 483 820 |
22-04-24 | 14,84 | +0,47% | 16 338 600 |
slotkoers Shanghai S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-35,56% | 1,88 mld. | |
+25,83% | 653 mld. | |
+27,00% | 556 mld. | |
-6,76% | 354 mld. | |
+20,34% | 331 mld. | |
+3,00% | 296 mld. | |
+13,09% | 233 mld. | |
+5,46% | 201 mld. | |
-9,61% | 193 mld. | |
-6,26% | 144 mld. |